India And New Zealand Free Trade Agreement [Signed On 27 April 2026]

The India – New Zealand Free Trade Agreement [FTA], has been signed on 27 April 2026 in Delhi and is a comprehensive economic partnership designed to bolster bilateral trade, investment and professional mobility. It is a trade pact designed to expand goods trade, services access, investment, mobility and regulatory cooperation while protecting sensitive sectors and creating a more predictable trade framework.

Beyond tariff concessions, the FTA places significant emphasis on trade facilitation, rules of origin, regulatory transparency, services market access, and sustainable development, thereby providing a predictable and rules-based environment for businesses engaged in cross-border trade and investment.

A central feature is that New Zealand has committed to extensive duty-free market access across its tariff schedule for India’s exports on entry into force, while India has offered tariff liberalisation on 70.03% of tariff lines covering 95% of bilateral trade value, with sensitive sectors such as dairy and several key agricultural products excluded.

The agreement also includes new pathways for skilled mobility, student mobility, post-study work rights, and a stated investment facilitation commitment of USD 20 billion into India.

Key features of the India-New Zealand FTA

1. Liberalisation in Trade in Goods

The India–New Zealand FTA provides for the progressive elimination or reduction of customs duties on originating goods, in accordance with the detailed tariff schedules set out in Annex 2A to the Agreement. These schedules lay down product‑wise staging commitments agreed by each Party, ensuring a transparent and predictable pathway for duty reduction over defined timelines. The tariff architecture reflects a calibrated balance between rapid market access and protection of sensitive domestic sectors, thereby offering certainty to exporters while allowing domestic industries time to adjust.

A significant feature of the Agreement is the grant of immediate duty‑free market access (“EIF – Entry into Force”) by New Zealand for a substantial share of Indian exports. Upon entry into force of the FTA, a large number of Indian products will become eligible for zero customs duty in the New Zealand market, without any transitional period. This upfront liberalisation substantially improves the price competitiveness of Indian goods and is expected to accelerate export growth, particularly in established and high‑value sectors.

On the Indian side, tariff liberalisation for sensitive products follows phased reduction schedules, classified under staging categories such as E3, E5, E7 and E10, under which duties are reduced gradually over 3, 5, 7 or 10 years, respectively. This staggered approach allows the Indian industry to absorb competitive pressures from imports while still complying with India’s market‑access commitments under the FTA. Such calibrated staging is particularly relevant for agricultural and select industrial products where domestic sensitivities exist.

The Agreement also incorporates a Most‑Favoured‑Nation (MFN) fallback protection mechanism, under which importers may be entitled to claim the lower rate if, at any time, the applicable MFN duty becomes lower than the preferential FTA rate. This safeguard ensures that FTA preferences do not result in an adverse duty outcome and preserves the principle that traders should always benefit from the lowest legally applicable customs duty.

In addition to product‑specific tariff concessions, the FTA provides for duty‑free entry of commercial samples of negligible value and printed advertising materials, subject to prescribed conditions. This facilitation measure directly supports marketing, business development, and trade promotion activities by reducing procedural and cost barriers at the border, especially for first‑time exporters and SMEs.

Commercial Impact:

The tariff liberalisation framework under the FTA delivers predictable market access, enhanced price competitiveness, and improved supply‑chain certainty. Indian exporters, particularly in textiles, engineering goods, pharmaceuticals, machinery and manufactured products, stand to gain from immediate or accelerated duty elimination in the New Zealand market. Actual benefit realisation will depend on strict compliance with Rules of Origin and related procedural requirements. Correspondingly, selected New Zealand agricultural and primary products benefit from structured and time‑bound access into India.

2. Rules of Origin and Preferential eligibility

Under the India–New Zealand FTA, goods are eligible for preferential tariff treatment only if they qualify as originating goods in accordance with the Rules of Origin prescribed in Chapter 3 and Annex 3A (Product Specific Rules). A good will qualify as originating where it is wholly obtained or produced in the territory of one or both Parties, or where it satisfies the applicable product‑specific origin rules. These product‑specific rules typically require either a change in tariff classification, such as a Change in Tariff Heading (CTH) or Change in Tariff Sub‑Heading (CTSH), or compliance with a prescribed Qualifying Value Content (QVC) threshold, ensuring that a minimum level of value addition takes place within the FTA Parties.

A key facilitative feature of the Agreement is the availability of bilateral cumulation, under which materials originating in either India or New Zealand are treated as originating when used in the production of a finished good in the other Party. This provision enables manufacturers to structure production processes across both jurisdictions without losing preferential origin status, thereby promoting cross‑border supply‑chain integration and deeper industrial collaboration.

To address practical manufacturing realities, the Agreement also incorporates de‑minimis thresholds that allow limited use of non‑originating materials without disqualifying the final product from preferential treatment. For most goods, non‑originating inputs may be used generally up to 10% of the FOB value of the finished product, with a lower 1% tolerance limit [in terms of weight and value of non-originating material] for wholly produced goods. Special de‑minimis rules, based on weight or value, apply to textiles and textile articles falling under HS Chapters 50–63, recognising the complexity and globalised nature of textile supply chains.

Commercial Impact: The Rules of Origin framework under the FTA supports the development of regional value chains and offers substantial flexibility to manufacturers sourcing limited inputs from third countries. Bilateral cumulation and de‑minimis provisions significantly reduce the risk of loss of preferential benefits due to minor non‑originating inputs, thereby lowering compliance risk, enhancing certainty at the time of import, and making preferential market access commercially viable for a wider range of exporters.

3. Trade facilitation and Customs Procedures

The India–New Zealand FTA places strong emphasis on modernising customs procedures with a view to ensuring speed, predictability and efficiency in cross‑border trade. A key commitment under the Agreement relates to time‑bound release of goods, with standard consignments required to be released within 48 hours of arrival, provided all prescribed information and documentation have been duly submitted and the goods are not selected for physical examination. For express consignments and perishable goods, the Agreement goes a step further by mandating release within 24 hours, subject to regulatory clearances and risk based selection, thereby addressing the critical need for time‑sensitive logistics and freshness‑linked supply chains.

To reduce uncertainty at the pre‑import stage, the FTA obligates both Parties to issue binding advance rulings prior to importation on matters relating to tariff classification, customs valuation and determination of origin. Such advance rulings provide legal certainty to importers and exporters on key customs issues, minimise post‑import disputes, and enable informed pricing and contracting decisions. Advance rulings are required to be issued within prescribed timelines and remain binding for a defined period, unless the underlying law or facts change.

The Agreement further mandates extensive digitisation and automation of customs processes, including electronic filing and processing of customs declarations, use of single‑window systems, and rationalisation of documentation requirements. These measures are designed to reduce compliance costs, eliminate duplicative filings across regulatory agencies, and enhance transparency in customs administration. Importantly, the FTA explicitly provides that neither Party shall require the mandatory use of licensed customs brokers solely as a condition for importation or exportation under the FTA, thereby giving traders procedural flexibility and control over their logistics operations.

Post‑clearance controls under the FTA are structured around risk‑management principles, with an increased reliance on post‑clearance audit rather than routine border‑level intervention. Customs authorities are encouraged to focus enforcement efforts on high‑risk consignments while facilitating swift clearance for compliant traders. This shift aligns with global best practices and the WTO Trade Facilitation Agreement, fostering a compliance‑based regulatory environment rather than a transaction‑oriented enforcement model.

Commercial Impact: The customs and trade facilitation commitments under the FTA translate into faster cargo release, reduced dwell time at ports, lower transaction and compliance costs, and fewer logistics bottlenecks. Predictable release timelines and advance rulings significantly mitigate clearance‑related risks, while digitisation and removal of mandatory broker requirements enhance operational efficiency. These measures are particularly beneficial for sectors with high logistics sensitivity, such as pharmaceuticals, engineering goods, perishables, and just‑in‑time manufacturing supply chains.

4. Sanitary and Phytosanitary (SPS) measures and Technical Barriers to Trade

The India–New Zealand FTA reaffirms both Parties’ commitment to WTO‑compliant Sanitary and Phytosanitary (SPS) measures under Chapter 6 and Technical Barriers to Trade (TBT) disciplines under Chapter 7, ensuring that regulatory requirements affecting trade remain science‑based, transparent and non‑discriminatory. The Agreement recognises that while each Party retains the sovereign right to protect human, animal and plant life and health, such measures should not be applied in a manner that constitutes unjustified barriers to trade.

A central feature of the SPS and TBT framework is the emphasis on risk‑based import checks, under which regulatory scrutiny is aligned with the actual risk profile of goods rather than routine or blanket inspections. The Agreement encourages the use of equivalence and regionalisation principles, allowing the importing Party to recognise that different regulatory systems or disease‑free regions of the exporting Party can achieve the same level of protection. These provisions are particularly relevant for agri‑food and animal‑origin products, where recognition of regional conditions and controls can significantly facilitate market access.

The FTA also places strong focus on digitalisation and paperless trade, including the promotion of electronic SPS certification and exchange of information between competent authorities. Movement towards electronic certification is intended to reduce delays caused by physical documentation, minimise administrative errors and enhance traceability and transparency in regulatory processes. This commitment aligns with global best practices and supports faster border clearance for regulated products.

Further, the Agreement includes sector‑specific annexes addressing regulatory cooperation in key sensitive sectors such as medical devices, pharmaceuticals, and trade in wine, whisky and other distilled spirits. These annexes provide tailored frameworks for cooperation, transparency, and dialogue between regulators, taking into account the unique regulatory and safety considerations applicable to each sector. By addressing sector‑specific challenges upfront, the Agreement reduces ambiguity and promotes smoother implementation of SPS and TBT measures in high‑compliance industries.

Commercial Impact:

The SPS and TBT provisions under the FTA significantly reduce regulatory friction, compliance uncertainty and border‑related delays for exporters. Enhanced reliance on risk‑based controls, equivalence, regionalisation and electronic certification is expected to particularly benefit food, agricultural, pharmaceutical and medical device exports, where regulatory barriers often have a greater trade‑restrictive effect than tariffs. Overall, these measures improve predictability, lower compliance costs and strengthen confidence for businesses operating in regulated cross‑border markets.

To view the full article click here

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.